Press Releases

Jan 6th, 2026

Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]
Dec 24th, 2025

Notice Concerning the Cancellation of Treasury Shares[English Disclosure Information]
Nov 18th, 2025

Notice Concerning the Status and Program Completion of Repurchase of Own Shares[English Disclosure Information]
Nov 14th, 2025

Ajinomoto Co., Inc. and Forge Biologics Develops Culture Media Supplements to Improve Productivity of Gene Therapy Products
Nov 6th, 2025

Consolidated Financial Results for the Six Months Ended September 30, 2025[English Disclosure Information]
Nov 6th, 2025

Notice Concerning Determination of Matters Related to Repurchase of Own Shares[English Disclosure Information]
Nov 5th, 2025

Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]
Oct 31st, 2025

Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology
Oct 14th, 2025

Ajinomoto Co., Inc. Files Patent Infringement Suits in China and Japan Regarding Its Manufacturing Process for Monosodium Glutamate (MSG) Products
Oct 2nd, 2025

Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]